Discussion on Determination of RAB Plan for Research and Development of Tetravalent Dengue Vaccines in Indonesian Isolates

Discussion on Determination of RAB Plan for Research and Development of Tetravalent Dengue Vaccines in Indonesian Isolates

Discussion on Determination of RAB Plan for Research and Development of Tetravalent Dengue Vaccines in Indonesian Isolates

Para penelititi dari Litbangkes

Researchers from Litbangkes

Staf dan Peneliti Pusat Studi Satwa Primata

Staff and Research Center for Primate Animal Studies

Staf dan Peneliti Pusat Studi Satwa Primata-IPB

Staff and Researchers of Primate-IPB Animal Study Centers

In connection with the development and research of the Dengue Vaccine conducted in a consortium, on Tuesday, May 22, 2018, researchers from Litbangkes namely Dr.dr C.S Whinie Lestari, M.Kes as the coordinator of the Consortium, Dr. Ni Ketut Susilarini, MS, Head of Sub. Bid. Non-Communicable Diseases, Balitbangkes, Drh. Rita Marleta Dewi, M.Kes research team, and Hambrah Dewi were present in the PSSP courtroom to discuss the continuation of the RAB Determination Discussion.

From the PSSP itself was present the Head of the PSSP Center Drh. Huda S Darusman, MSi, PhD, Secretary General Dr. Ir Entang Iskandar, MSi, Dr. drh Joko Pamungkas, MSc and Dr. Diah Iskandriati as consortium members and researchers and head of laboratories related to this research.

In this meeting discussed the preparation of research designs related to vaccine testing in primates, budgeting and preparation of PKS between the two parties.